Drittmittelprojekte

Public Health Genetics: Development, Conception, Normative Evaluation

Literatur

• CENTERS OF DISEASE CONTROL AND PREVENTION IN THE UNITED STATES (1997). Translating Advances in Human Genetics into Public Health Action: A Strategic Plan, Unpublished Draft by the Centers of Disease Control and Prevention, CDC, 3rd of September 1997
• HOLTZMAN, N. A. (1989). Proceed With Caution: Predicting Genetic Risks in the Recombinant DNA Era. Baltimore, John Hopkins University Press
• HOLTZMAN, N. A. and T. M. MARTEAU (2000). „Will Genetics Revolutionize Medicine?” New England Journal of Medicine 343(2): 141-144
• JUDSON, R. and J. C. STEPHENS (2001). „Notes From the SNP vs. Haplotype Front.” Pharmacogenomics 2(1): 7-10
• JUENGST, E. T. (1995). „'Prevention' and the Goals of Genetic Medicine.” Human Gene Therapy 6: 1595-1605
• JUENGST, E. T. (1997). „Caught in the Middle Again: Professional Ethical Considerations in Genetic Testing for Health Risks.” Genet Test 1(3): 189-200
• KHOURY, M. J., W. BURKE, et al., eds. (2000). Genetics and Public Health in the 21st Century. Using Genetic Information to Improve Health and Prevent Disease. New York, NY, Oxford University Press
• KHOURY, M. J., W. BURKE, et al. (2000). Genetics and Public Health: A Framework for the Integration of Human Genetics into Public Health Practice. In: Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease. M. J. KHOURY, W. BURKE and E. J. THOMSON, eds., New York, NY, Oxford University Press: 3-23
• KOENIG, B. A., H. T. GREELY, et al. (1998). „Genetic Testing for BRCA1 and BRCA2: Recommendations of the Stanford Program in Genomics, Ethics, and Society. Breast Cancer Working Group.” Journal of Womens Health 7(5): 531-545
• LENOIR, T. (1999). Shaping Biomedicine as an Information Science. In: Proceedings of the 1998 Conference on the History and Heritage of Science Information Systems. M. E. BOWDEN, T. B. HAHN and R. V. WILLIAMS, eds., Medford, NJ: 27-45
• MARTEAU, T. and M. RICHARDS, eds. (1996). The Troubled Helix: Social and Psychological Implications of the New Human Genetics. New York, NY, Cambridge University Press
• PAUL, N. W. (2002). Molekulare Prädiktion: Ein Weg zur Molekularen Prävention? In: Innovative Aspekte in der Prävention. J. G. GOSTOMZYK, ed., München: 39-61
• PAUL, N. W. (2003). Genetische Intervention - Genetische Prävention - Genetisches Design? Zu Entwicklung, Optionen und Konsequenzen der Molekularen Medizin. In: Moderne Biologie: Möglichkeiten und Risiken, Hoffnung und Bedrohung. M. ANDEL, T. RUZICKA, A. LABISCHet al, eds., Praha, Tigis: 77-85
• PAUL, N. W. (2004). „Societal Implications of a Wide-spread Predictive Testing for Hereditary Tumors.” Journal of Cancer Research and Clinical Oncology 130(Supp.1): 26
• PAUL, N. W. and D. GANTEN (2003). Zur Zukunft der Molekularen Medizin. In: Das genetische Wissen und die Zukunft des Menschen. L. HONNEFELDER, D. MIETH, P. PROPPING, L. SIEP and C. WIESEMANN, eds., Berlin, De Gruyter: 103-114
• PAUL, N. W. and A. LABISCH (2002). „Health is a Crossroad: Natur und Gesellschaft, Individuum und Gemeinschaft in der öffentlichen Gesundheitssicherung.” Das Gesundheitswesen 64: 614-622
• PELTONEN, L. and V. A. MCKUSICK (2001). „Dissecting Human Disease in the Postgenomic Era.” Science 291: 1224-1229
• RILEY, J. H., C. J. ALLAN, et al. (2000). „The Use of Single Nucleotide Polymorphisms in the Isolation of Common Disease Genes.” Pharmacogenomics 1(1): 39-47
• WORLD HEALTH ORGANIZATION (WHO) (1997). Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Services. Report of a WHO Meeting on Ethical Issues in Medical Genetics, 15-16 Dec. 1997. Geneva, WHO
• YOUNG, I. D. (1999). Introduction to Risk Calculation in Genetic Counseling. Oxford [England]; New York, Oxford University Press